Compare Citius Pharmaceuticals Inc (CTXR) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs NetEase Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while NetEase Inc trades at $122.96 (market cap $82.75B). The key difference: NetEase Inc is far larger — about 4135.4× Citius Pharmaceuticals Inc's market cap, and NetEase Inc pays a 2.36% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | NTES | |
|---|---|---|
Market Cap | $20.01M | $82.75B |
Sector | Health | Media |
52-Week High | $1.82 | $159.34 |
52-Week Low | $0.48 | $109.26 |
Enterprise Value | $16.23M | $59.05B |
Dividend Yield | — | 2.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
